BSE filing, NSE: SWITCHTE. Summary written from the filing by ALFA Finder's alert engine.
Switching Technologies Gunther Ltd: key numbers
- Share price
- ₹135.60
- Market cap
- ₹33.22 Cr
- Revenue (annual)
- ₹8.25 Cr
- Net profit (annual)
- ₹6.55 Cr
- P/E (TTM)
- 5.1×Sector 43.1×
- Promoter holding
- 58.27%+0.00% QoQ
- FII holding
- 0.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Switching Technologies Gunther Ltd
All →Switching Technologies Gunther Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Switching Technologies Gunther Annual General Meeting
Switching Technologies Gunther Ltd conducted its 38th Annual General Meeting on 24th September 2026, approving financial statements, director appointments, office relocation, and related party transactions.
Switching Technologies Gunther Management Change
Switching Technologies Gunther Ltd announced the appointment of a new CFO and Company Secretary, alongside a designation change for a Director and the resignation of the existing CS.
Switching Technologies Gunther Board Meeting Date
Switching Technologies Gunther has scheduled a Board Meeting on 24 Sep 2026 to approve a new CFO, Company Secretary, and a director redesignation. The meeting is yet to be held; agenda items remain proposed.
Switching Technologies Gunther Annual Report
Switching Technologies Gunther Limited submitted its 38th Annual Report for FY 2025-26. The filing includes the AGM notice scheduled for September 24, 2026.
Switching Technologies Gunther Annual General Meeting
Switching Technologies Gunther Ltd has scheduled its 38th Annual General Meeting for September 24, 2026. The book closure for the event is set from September 18 to September 24, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.